Lactobacillus reuteriGMNL-263
Good metabolic control is associated with better quality of life
Potential commercial applications:
Metabolic syndrome is a condition characterized by central obesity, hypertension, and disturbed glucose and insulin metabolism and high cholesterol that increases the risk of heart disease. More than 50 million Americans suffer from metabolic syndrome, and half of the population is predisposed to it. And metabolic syndrome is also the major recent challenge in medical or food science in developed/developing counties.
A daily dose of probiotics may prevent weight gain and insulin resistance in mice, says a new study from scientists at the US National Institutes of Health (NIH) with implications for obesity and diabetes. J. Biol. Chem. published online July 8, 2013
patents
A daily dose of probiotics may prevent weight gain and insulin resistance in mice, says a new study from scientists at the US National Institutes of Health (NIH) with implications for obesity and diabetes. J. Biol. Chem. published online July 8, 2013
patents
■CN Patent ZL 201210404018.9
■TW Patent I340021
■US Patent US 8298526
■JP Patent 5185976
■EU Patent EP 2543379
Efficacy Test
Potential commercial applications:
●Form: powder, sachet, tablet
●Increase the added-value of the original product: Probiotic GMNL -263 can be added into fermentation products, dietary supplement, milk (fresh/powder) and sports drinks to enhance the nutrition values
Targeted users:
●People who suffer from insulin resistance
●People with hyperinsulinism, glucose intolerance and hyperlipidemia
●People who want to reduce body fat, blood lipid
●Metabolic diseases